八中心回顾性临床实践数据分析:基于算法的促卵泡激素δ治疗
在德国八个生殖医学中心回顾性分析2018年1月至2019年6月360例接受促卵泡激素δ卵巢刺激女性的质量监控数据,评估基于体重和抗苗勒管激素(AMH)的个体化剂量算法在常规临床实践中的疗效。首个周期平均获卵11.2枚,42.1%患者获8-14枚卵,新鲜胚胎移植临床妊娠率38.2%,累积妊娠率49.4%。
要点
- 基于体重和AMH的促卵泡激素δ剂量算法在常规实践中获卵8-14枚者占42.1%。
- 首个新鲜胚胎移植周期临床妊娠率38.2%,平均移植1.4枚胚胎。
- 首个刺激周期累积妊娠率49.4%(含该周期冷冻保存周期)。
核心结论
- 尽管治疗前AMH值范围宽,42.1%患者达到获卵8-14枚的目标,并获得很好的临床妊娠率,基于算法的促卵泡激素δ卵巢刺激在临床实践中仍然高度有效。
研究设计与样本
- 德国八个生殖医学中心2018年1月至2019年6月质量监控中360例接受促卵泡激素δ卵巢刺激女性的观察性数据,回顾性分析。
主要发现
- 患者平均年龄33.5(±3.8)岁。
- 治疗前AMH浓度从<0.5 ng/ml或3.6 pmol/l(2.5%)到>5.6 ng/ml或40 pmol/l(19.7%),79.7%的AMH测量值高于2.0 ng/ml或14.5 pmol/l。
- n=359个首个促卵泡激素δ周期的平均获卵数为11.2(±6.7)枚,42.1%患者在取卵时获卵8-14枚。
- 首个周期新鲜胚胎移植的平均临床妊娠率为38.2%,平均每移植1.4枚胚胎。
- 首个刺激周期的累积妊娠率为49.4%(包括由首个刺激周期产生的冷冻保存周期)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can efficacy and success rates of the first recombinant FSH expressed in a human cell line with an individualized dosing algorithm based on body weight and anti-Müllerian hormone (AMH) as shown in the ESTHER-1 trial be confirmed in routine clinical practice? DESIGN: In eight reproductive medicine centres in Germany, observational data of 360 women who underwent ovarian stimulation with follitropin delta were evaluated as part of the quality control from January 2018 to June 2019. The data were analysed retrospectively. RESULTS: Mean age of patients was 33.5 (±3.8) years. Pretreatment AMH concentrations ranged from <0.5 ng/ml or 3.6 pmol/l (2.5%) to >5.6 ng/ml or 40 pmol/l (19.7%), with 79.7% of all AMH measurements above 2.0 ng/ml or 14.5 pmol/l. The mean number of oocytes obtained in n = 359 first follitropin delta cycles was 11.2 (±6.7) oocytes with 42.1% of patients having between eight and 14 oocytes retrieved at oocyte retrieval. The average clinical pregnancy rate in the first cycle with a fresh embryo transfer was 38.2% with a mean of 1.4 embryos per transfer. The cumulative pregnancy rate was 49.4% for the first stimulation cycle (including cryopreservation cycles generated from the first stimulation cycle). CONCLUSION: The goal of obtaining an adequate number of oocytes (8-14 oocytes) using the follitropin delta dosing algorithm was reached in 42.1% of patients despite a wide range of pretreatment AMH values, while achieving very good clinical pregnancy rates. Hence, algorithm-based ovarian stimulation with follitropin delta remains highly effective in clinical practice.
引用
- Bachmann A, Kissler S, Laubert I, et al. An eight centre, retrospective, clinical practice data analysis of algorithm-based treatment with follitropin delta. Reprod Biomed Online. 2021. PMID: 35193799. doi:10.1016/j.rbmo.2021.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。